How Price Transparency Caused Patients to Gripe Loudly about the Skyrocketing Cost of Mylan’s EpiPen and Why Clinical Laboratories Should Watch Next Developments

Oct 5, 2016 | Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Sales and Marketing, Laboratory Testing

Medical laboratory managers are getting an important lesson in the power of price transparency to motivate patients to complain about arbitrarily high prices for healthcare services and products By now, most clinical laboratory managers and pathologists know about the EpiPen pricing scandal. Simply said, it illustrates all the flaws and problems in the US healthcare system that make it possible for vendors and providers to raise prices arbitrarily and stick the bill on health insurers,...
;